Lovastatin
- Product NDC
- 50090-3216
- Requested package NDC
- 50090-3216-0
- 11-digit product format
- 500903216
- Labeler code
- 50090
- Product ID
- 50090-3216_63db6524-2ace-4bd6-9758-537b4960c754
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- Lovastatin
- Dosage form
- TABLET
- Route
- ORAL
- Labeler
- A-S Medication Solutions
- Application
- ANDA075551
- Marketing category
- ANDA
- Marketing start
- 2001-12-17
- Marketing end
- 0000-00-00
- Substance
- LOVASTATIN
- Active strength
- 40 mg/1
- Pharmacologic classes
- HMG-CoA Reductase Inhibitor [EPC],Hydroxymethylglutaryl-CoA Reductase Inhibitors [MoA]
- NDC exclude flag
- No
- Listing certified through
- 2022-12-31
- Current FDA listing
- Historical FDA.report record
NDC auxiliary status#
Explicit status records from FDA unfinished, excluded, and compounder auxiliary files. Absence of a row is not itself a regulatory status. Browse every current auxiliary row, including rows without a usable NDC. · Browse every captured source and parsed snapshot.
| Dataset | Scope | Product NDC | Package NDC | Code | Status | Reporting period | Source date |
|---|---|---|---|---|---|---|---|
| excluded package | package | 50090-3216 | 50090-3216-0 | D | Discontinued by firm | 2026-07-31 |
Orange Book products#
| Application-product | Trade name | Ingredient | Strength | Dosage form / route | TE codes | RLD / RS | Approval date |
|---|---|---|---|---|---|---|---|
| A075551-001 | LOVASTATIN | LOVASTATIN | 40MG | TABLET / ORAL | AB | 2001-12-17 | |
| A075551-002 | LOVASTATIN | LOVASTATIN | 20MG | TABLET / ORAL | AB | 2001-12-17 | |
| A075551-003 | LOVASTATIN | LOVASTATIN | 10MG | TABLET / ORAL | AB | 2001-12-17 |
Therapeutic equivalence codes#
| Application-product | TE code |
|---|---|
| A075551-001 | AB |
| A075551-002 | AB |
| A075551-003 | AB |
Observed Orange Book product history#
Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.
| Captured | Edition | Application-product | Trade name | Strength | Dosage form / route | Product TE source text | RLD / RS | Approval date | Source SHA-256 |
|---|---|---|---|---|---|---|---|---|---|
| 2026-08-01 22:54:32 | 2026-06 | A075551-001 | LOVASTATIN | 40MG | TABLET / ORAL | AB | 2001-12-17 | a50c72e98297… | |
| 2026-08-01 22:54:32 | 2026-06 | A075551-002 | LOVASTATIN | 20MG | TABLET / ORAL | AB | 2001-12-17 | a50c72e98297… | |
| 2026-08-01 22:54:32 | 2026-06 | A075551-003 | LOVASTATIN | 10MG | TABLET / ORAL | AB | 2001-12-17 | a50c72e98297… |
Observed Orange Book normalized TE history#
| Captured | Edition | Application-product | TE code | Order | Source SHA-256 |
|---|---|---|---|---|---|
| 2026-08-01 22:54:32 | 2026-06 | A075551-001 | AB | 1 | a50c72e98297… |
| 2026-08-01 22:54:32 | 2026-06 | A075551-002 | AB | 1 | a50c72e98297… |
| 2026-08-01 22:54:32 | 2026-06 | A075551-003 | AB | 1 | a50c72e98297… |
openFDA label cross-check#
Cross-check layer: openFDA label JSON enriches search and identifies hydration gaps. The DailyMed Structured Product Label remains the canonical label presentation on FDA.report. Every label matching the complete exact-identifier union is deduplicated and paginated below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Lovastatin | LOVASTATIN | REMEDYREPACK INC. | a902a95f-072a-4487-99a9-109a93f8b23c | 2026-04-03 | Warnings, Adverse reactions | 075551 ANDA075551 |
| Lovastatin | LOVASTATIN | Golden State Medical Supply, Inc. | 91332c54-1a27-4e6b-e053-2a95a90a42cd | 2025-12-15 | Warnings, Adverse reactions | 075551 ANDA075551 |
| Lovastatin | LOVASTATIN | A-S Medication Solutions | 4ff981e8-5c86-4b86-baa1-825551905ed8 | 2024-12-12 | Warnings, Adverse reactions | 075551 ANDA075551 50090-3216-0 50090-3216 50090321600 |
| Lovastatin | LOVASTATIN | Aphena Pharma Solutions - Tennessee, LLC | 7e96b174-3887-4908-9b9f-5ef93540f96a | 2023-05-31 | Warnings, Adverse reactions | 075551 ANDA075551 |
| Lovastatin | LOVASTATIN | Teva Pharmaceuticals USA, Inc. | 0e15feec-d27e-4861-8152-c5a8b8ccacd4 | 2020-08-01 | Warnings, Adverse reactions | 075551 ANDA075551 |
| Lovastatin | LOVASTATIN | Proficient Rx LP | 027bd594-6a0a-4e6d-bd3c-4f33fdb4166a | 2020-04-01 | Warnings, Adverse reactions | 075551 ANDA075551 |
DailyMed Product Concepts#
| Product concept | Relation | Version | Effective |
|---|---|---|---|
| dc9a5fb6-14e2-1cc8-a567-a781fd1f0212 | Product name | 1 | 20140508 |
| f1ae760e-e8ec-b0b4-fb1b-2db7c49fcec5 | Product name | 1 | 20140508 |
| fecc3d5d-ff9a-60ad-1a3a-6cb9b21df758 | Product name | 1 | 20140508 |
FDA-Initiated Inactive NDC Indexing#
| NDC | Effective | Action | Document | Indexing SPL | Related label |
|---|---|---|---|---|---|
| 50090-3216-0 | 2024-12-12 | C162847 | 48780-1 | f386c64a-41ca-0266-e053-dadaa90a7c1a | Lovastatin Tablets, USP Rx only |
| 50090-3216-2 | 2024-12-12 | C162847 | 48780-1 | f386c64a-41ca-0266-e053-dadaa90a7c1a | Lovastatin Tablets, USP Rx only |
| 50090-3216-0 | 2023-01-30 | C162847 | 48780-1 | f386c64a-41ca-0266-e053-dadaa90a7c1a | Lovastatin Tablets, USP Rx only |
| 50090-3216-2 | 2023-01-30 | C162847 | 48780-1 | f386c64a-41ca-0266-e053-dadaa90a7c1a | Lovastatin Tablets, USP Rx only |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 50090-3216-0 | Lovastatin | 30 in 1 BOTTLE | TABLET | 30 | 8 | |
| 50090-3216-2 | Lovastatin | 90 in 1 BOTTLE, PLASTIC | TABLET | 90 | 8 |
DailyMed Billing Units#
| Package NDC | Billing unit | Product NDC | DailyMed indexing SPL | SPL version | Effective |
|---|---|---|---|---|---|
| 50090-3216-0 | EA - Each | 50090-3216 | 1a257184-97c2-4d36-aa65-f736298f6a47 | 1 | 2019-05-02 |
| 50090-3216-2 | EA - Each | 50090-3216 | f58de7cf-5835-4907-a68d-f1af7c221612 | 1 | 2019-05-02 |
DailyMed Dashboard NDC Coverage#
| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|---|---|---|---|
| 50090-3216 | LOVASTATIN TABLET [A-S MEDICATION SOLUTIONS] | 8 | Legacy NDC, 2 package rows | 20241215_4ff981e8-5c86-4b86-baa1-825551905ed8.zip |
DailyMed RxNorm Mappings#
| RxCUI | RxNorm string | TTY | DailyMed | SPL version |
|---|---|---|---|---|
| 197903 | lovastatin 10 MG Oral Tablet | PSN | 4ff981e8-5c86-4b86-baa1-825551905ed8 | 8 |
| 197905 | lovastatin 40 MG Oral Tablet | PSN | 4ff981e8-5c86-4b86-baa1-825551905ed8 | 8 |
| 197903 | lovastatin 10 MG Oral Tablet | SCD | 4ff981e8-5c86-4b86-baa1-825551905ed8 | 8 |
| 197905 | lovastatin 40 MG Oral Tablet | SCD | 4ff981e8-5c86-4b86-baa1-825551905ed8 | 8 |
Packages#
| Package NDC | 11-digit format | Description | Units | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|---|---|---|---|---|---|---|---|
| 50090-3216-0 | 50090321600 | 30 TABLET in 1 BOTTLE (50090-3216-0) | 30 tablet | 2017-11-29 | 0000-00-00 | No | No | Current |